HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

methyl indoxam

structure in first source

Networked: 2 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Biphenyl Compounds: 7
        methyl indoxam: 2
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - methyl indoxam: 2

Experts

1.	Cash, James G: 1 article (10/2018)
2.	Hegde, Narasimha: 1 article (10/2018)
3.	Hui, David Y: 1 article (10/2018)
4.	Konaniah, Eddy: 1 article (10/2018)
5.	Kuhel, David G: 1 article (10/2018)
6.	Romick-Rosendale, Lindsey: 1 article (10/2018)
7.	Watanabe, Miki: 1 article (10/2018)
8.	Abousalham, A: 1 article (08/2009)
9.	Buysse, J: 1 article (08/2009)
10.	Chang, H-T: 1 article (08/2009)

Related Diseases

1.	Hyperlipidemias (Hyperlipidemia) 10/01/2018 - "The second study examined the effectiveness of the non-absorbable secretory phospholipase A2 inhibitor methyl indoxam to reverse hyperglycemia and hyperlipidemia in HFHC diet-fed C57BL/6 mice after diabetes onset. " 10/01/2018 - "Importantly, treatment of wild type mice with methyl indoxam after HFHC diet-induced onset of hyperlipidemia and hyperglycemia effectively restored normal plasma lipid and glucose levels and replicated the metabolic benefits of VSG surgery with diabetes remission and TMAO reduction. "
2.	Hyperglycemia 10/01/2018 - "The second study examined the effectiveness of the non-absorbable secretory phospholipase A2 inhibitor methyl indoxam to reverse hyperglycemia and hyperlipidemia in HFHC diet-fed C57BL/6 mice after diabetes onset. " 10/01/2018 - "Importantly, treatment of wild type mice with methyl indoxam after HFHC diet-induced onset of hyperlipidemia and hyperglycemia effectively restored normal plasma lipid and glucose levels and replicated the metabolic benefits of VSG surgery with diabetes remission and TMAO reduction. "
3.	Obesity 08/01/2009 - "These results show that oral supplementation of a diabetogenic diet with the Pla2g1b inhibitor methyl indoxam effectively suppresses diet-induced obesity and diabetes in mice. " 08/01/2009 - "This study examined the potential of using the Pla2g1b inhibitor methyl indoxam as therapy to suppress diet-induced obesity and diabetes. " 08/01/2009 - "The phospholipase A(2) inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice."
4.	Glucose Intolerance 08/01/2009 - "Methyl indoxam suppression of diet-induced body weight gain and glucose intolerance was correlated with the inhibition of Pla2g1b-mediated postprandial lysophospholipid absorption. " 08/01/2009 - "The phospholipase A(2) inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice."
5.	Body Weight (Weight, Body) 08/01/2009 - "In contrast, C57BL/6 mice fed the diabetogenic diet with 90 mg.kg(-1) of methyl indoxam gained only 5% body weight after 10 weeks. " 08/01/2009 - "Methyl indoxam suppression of diet-induced body weight gain and glucose intolerance was correlated with the inhibition of Pla2g1b-mediated postprandial lysophospholipid absorption. "

Related Drugs and Biologics

1.	Lipids
2.	Glucose (Dextrose)
3.	trimethyloxamine (trimethylamine N-oxide)
4.	Secretory Phospholipases A2
5.	Phospholipases (Phospholipase)
6.	Lysophospholipids

Related Therapies and Procedures

1.	Therapeutics